- Total raised
- Public
- Stage
- Public
- Team size
- 51-200 employees
- Founded
- 1999
- HQ
- Mountain View
About NeuroPace
NeuroPace develops and markets implantable devices for the treatment of neurological disorders.
Open roles · 5
- Open
Associate Therapy Consultant - Mid Atlantic South
Richmond, VA · remote
- Open
Director of Reimbursement
Mountain View, CA · on-site · $172k–228k
- Open
Associate Therapy Consultant (Sales Rep) - New York Metro
New York, NY · on-site
- Open
Associate Therapy Consultant - Los Angeles (Sales)
Los Angeles, CA · on-site
- Open
Senior Engineer, Test Development
Mountain View, CA · on-site · $132k–172k
Location
More startups in Mountain View
Cognition
San Francisco
The company is an applied AI lab that builds end-to-end software agents and collaborative AI teammates, enabling engineers to focus on more interesting problems and empowering teams to pursue ambitious goals; it markets Devin as the first A
Thinking Machines Lab
San Francisco
Thinking Machines Lab is a San Francisco AI research startup founded in 2025 by former OpenAI CTO Mira Murati, building interpretable, collaborative AI systems for professional and enterprise use. Its first product, Tinker, helps developers fine-tune models without managing distributed infrastructure.
Mind Robotics
Palo Alto
Mind Robotics develops artificial intelligence and robotics systems designed for industrial environments and manufacturing operations.
Xaira Therapeutics
South San Francisco
an integrated biotechnology company driving advances in AI to transform how we treat disease.
Poolside
San Francisco
Poolside is building the world's most capable AI for software development, focusing on distributed training and inference of large language models for source code generation, with a mission to unlock developers' potential through AI for sof
The Bot Company
San Francisco
The Bot Company builds household robots to give people back time, pursuing in-house AI, software and hardware. It plans to deploy millions at home before expanding, and has raised $300M, including a $150M Greenoaks-led round, valuing the co
